Search research articles
Contact Us
Filters
Showing results (61-70 of 111) with videos related to
Page
of 12
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
January 22, 2002
Viral IFN-regulatory factors inhibit activation-induced cell death via two positive regulatory IFN-regulatory factor 1-dependent domains in the CD95 ligand promoter
Sabine Kirchhoff, Thorsten Sebens, Sven Baumann, et al.
Brain Pathology (Zurich, Switzerland)
|
May 12, 2010
Extracellular matrix in multiple sclerosis lesions: Fibrillar collagens, biglycan and decorin are upregulated and associated with infiltrating immune cells
Hema Mohan, Markus Krumbholz, Rakhi Sharma, et al.
Neuro-Oncology
|
May 19, 2017
Soluble TACI and soluble BCMA as biomarkers in primary central nervous system lymphoma
Franziska S Thaler, Sarah A Laurent, Marion Huber, et al.
Journal of Neuroinflammation
|
December 20, 2015
Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid
Manfred Wuhrer, Maurice H J Selman, Liam A McDonnell, et al.
Journal of Neuroimmunology
|
June 17, 2008
BDNF and its receptors in human myasthenic thymus: implications for cell fate in thymic pathology
Angela Berzi, C Korcan Ayata, Paola Cavalcante, et al.
Frontiers in Cell and Developmental Biology
|
November 26, 2020
BAFF 60-mer, and Differential BAFF 60-mer Dissociating Activities in Human Serum, Cord Blood and Cerebrospinal Fluid
Mahya Eslami, Edgar Meinl, Hermann Eibel, et al.
Journal of Hematology & Oncology
|
October 17, 2019
APRIL and BAFF: novel biomarkers for central nervous system lymphoma
Matthias Mulazzani, Marion Huber, Sabine Borchard, et al.
Acta Neuropathologica
|
November 26, 2020
Archeological neuroimmunology: resurrection of a pathogenic immune response from a historical case sheds light on human autoimmune encephalomyelitis and multiple sclerosis
Eduardo Beltrán, Manuela Paunovic, David Gebert, et al.
Brain : a Journal of Neurology
|
November 11, 2005
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment
Markus Krumbholz, Diethilde Theil, Sabine Cepok, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
January 26, 2023
Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis
Samantha Ho, Eva Oswald, Hoi Kiu Wong, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 111) with videos related to
Sort By:
Page
of 12
Journal of Immunology (Baltimore, Md. : 1950)
|
January 22, 2002
Viral IFN-regulatory factors inhibit activation-induced cell death via two positive regulatory IFN-regulatory factor 1-dependent domains in the CD95 ligand promoter
Sabine Kirchhoff, Thorsten Sebens, Sven Baumann, et al.
Brain Pathology (Zurich, Switzerland)
|
May 12, 2010
Extracellular matrix in multiple sclerosis lesions: Fibrillar collagens, biglycan and decorin are upregulated and associated with infiltrating immune cells
Hema Mohan, Markus Krumbholz, Rakhi Sharma, et al.
Neuro-Oncology
|
May 19, 2017
Soluble TACI and soluble BCMA as biomarkers in primary central nervous system lymphoma
Franziska S Thaler, Sarah A Laurent, Marion Huber, et al.
Journal of Neuroinflammation
|
December 20, 2015
Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid
Manfred Wuhrer, Maurice H J Selman, Liam A McDonnell, et al.
Journal of Neuroimmunology
|
June 17, 2008
BDNF and its receptors in human myasthenic thymus: implications for cell fate in thymic pathology
Angela Berzi, C Korcan Ayata, Paola Cavalcante, et al.
Frontiers in Cell and Developmental Biology
|
November 26, 2020
BAFF 60-mer, and Differential BAFF 60-mer Dissociating Activities in Human Serum, Cord Blood and Cerebrospinal Fluid
Mahya Eslami, Edgar Meinl, Hermann Eibel, et al.
Journal of Hematology & Oncology
|
October 17, 2019
APRIL and BAFF: novel biomarkers for central nervous system lymphoma
Matthias Mulazzani, Marion Huber, Sabine Borchard, et al.
Acta Neuropathologica
|
November 26, 2020
Archeological neuroimmunology: resurrection of a pathogenic immune response from a historical case sheds light on human autoimmune encephalomyelitis and multiple sclerosis
Eduardo Beltrán, Manuela Paunovic, David Gebert, et al.
Brain : a Journal of Neurology
|
November 11, 2005
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment
Markus Krumbholz, Diethilde Theil, Sabine Cepok, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
January 26, 2023
Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis
Samantha Ho, Eva Oswald, Hoi Kiu Wong, et al.
Page
of 12